TOPORS expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.26960022892331E-10 |
Normal-vs-Stage2 |
2.44969999996236E-06 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
3.633400E-01 |
Stage1-vs-Stage3 |
2.11699999974613E-07 |
Stage1-vs-Stage4 |
6.26299999972879E-07 |
Stage2-vs-Stage3 |
9.978300E-02 |
Stage2-vs-Stage4 |
6.523600E-02 |
Stage3-vs-Stage4 |
6.535200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62592161956354E-12 |
Normal-vs-AfricanAmerican |
3.5294001055064E-10 |
Normal-vs-Asian |
6.226500E-04 |
Caucasian-vs-AfricanAmerican |
9.713800E-01 |
Caucasian-vs-Asian |
8.319600E-01 |
AfricanAmerican-vs-Asian |
8.290400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
3.40980021995563E-10 |
Male-vs-Female |
8.002700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.67279999746728E-08 |
Normal-vs-Age(41-60Yrs) |
1.52111656603893E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
6.17890000054189E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.276200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.424400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.626200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.062200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.913400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.969200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.690950E-01 |
Normal-vs-Grade 2 |
5.46699996384348E-09 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.778410E-01 |
Grade 1-vs-Grade 3 |
9.9649000000035E-05 |
Grade 1-vs-Grade 4 |
3.19469999998656E-06 |
Grade 2-vs-Grade 3 |
3.56619999974939E-07 |
Grade 2-vs-Grade 4 |
1.94399996100714E-09 |
Grade 3-vs-Grade 4 |
1.089750E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.96640000005299E-06 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
7.44626582616092E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63591362678517E-12 |
Normal-vs-N1 |
1.21190002477789E-09 |
N0-vs-N1 |
6.190400E-02 |
|
|